These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 549023)

  • 1. Pyridoxine therapy of adult primary oxalosis.
    Will EJ; Bijvoet OL
    Proc Eur Dial Transplant Assoc; 1979; 16():727-8. PubMed ID: 549023
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic effect of pyridoxine and succinimide in the treatment of a patient with primary hyperoxaluria].
    Jerez E; Rapado A
    Arch Esp Urol; 1986 May; 39(4):279-82. PubMed ID: 3740976
    [No Abstract]   [Full Text] [Related]  

  • 3. Pyridoxine therapy in patients with renal calcium oxalate calculi.
    Balcke P; Schmidt P; Zazgornik J; Kopsa H; Minar E
    Proc Eur Dial Transplant Assoc; 1983; 20():417-21. PubMed ID: 6657665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Oxaluria, nonfamilial hyperoxaluric form of oxalic lithiasis].
    Desgrez P; Thomas J; David-Issartel R
    J Urol Nephrol (Paris); 1968 Sep; 74(9):685-9. PubMed ID: 5718185
    [No Abstract]   [Full Text] [Related]  

  • 5. [Oxalosis].
    Broyer M; Berger R
    Presse Med (1893); 1968 Dec; 76(50):2395-6. PubMed ID: 5732646
    [No Abstract]   [Full Text] [Related]  

  • 6. Inorganic phosphate treatment of nephrolithiasis.
    Ettinger B; Kolb FO
    Am J Med; 1973 Jul; 55(1):32-7. PubMed ID: 4715930
    [No Abstract]   [Full Text] [Related]  

  • 7. [Pyridoxine can normalize oxaluria in idiopathic renal lithiasis].
    Jaeger P; Portmann L; Jacquet AF; Burckhardt P
    Schweiz Med Wochenschr; 1986 Dec; 116(50):1783-6. PubMed ID: 3798070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Cas Lek Cesk; 1982 Feb; 121(6):163-6. PubMed ID: 7060073
    [No Abstract]   [Full Text] [Related]  

  • 9. [Current trends in phosphotherapy. IV. Treatment of oxalic lithiasis].
    Eisinger J; d' Omezon Y; Recordier AM
    Mars Med; 1971; 108(9):605-8. PubMed ID: 5120435
    [No Abstract]   [Full Text] [Related]  

  • 10. [Animal-experiment studies on the effect of magnesium and vitamin B 6 on calcium-oxalate nephrolithiasis].
    Schneider HJ; Hesse A; Berg W; Kirsten J; Nickel H
    Z Urol Nephrol; 1977 Jun; 70(6):419-27. PubMed ID: 906678
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxalosis in infancy.
    de Zegher FE; Wolff ED; vd Heijden AJ; Sukhai RN
    Clin Nephrol; 1984 Sep; 22(3):114-20. PubMed ID: 6386251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary hyperoxaluria with normal alpha-ketoglutarate: glyoxylate carboligase activity. Treatment with isocarboxazid.
    Bourke E; Frindt G; Flynn P; Schreiner GE
    Ann Intern Med; 1972 Feb; 76(2):279-84. PubMed ID: 5009594
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary oxalosis: clinical and biochemical response to high-dose pyridoxine therapy.
    Will EJ; Bijvoet OL
    Metabolism; 1979 May; 28(5):542-8. PubMed ID: 449695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Acute renal failure caused by acute oxalosis after massive ingestion of pyridoxilate].
    Dequiedt P; Gosselin B; Benoit O; Le Maguer D; Lebleu J; MacNamara E; Pagniez D; Dracon M; Lelièvre G; Tacquet A
    Nephrologie; 1985; 6(5):228-30. PubMed ID: 4094637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Familial oxalosis. Study of 2 cases. Attempted treatment].
    Mathieu H; Gagnadoux MF; Mongour P; Czernichow P; Volter F; Kaplan M
    Bull Mem Soc Med Hop Paris; 1968; 119(9):719-30. PubMed ID: 5705150
    [No Abstract]   [Full Text] [Related]  

  • 16. Severe vascular complications in oxalosis after successful cadaveric kidney transplantation.
    Vanrenterghem Y; Vandamme B; Lerut T; Michielsen P
    Transplantation; 1984 Jul; 38(1):93-5. PubMed ID: 6377620
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of pyridoxine supplementation on recurrent stone formers.
    Murthy MS; Farooqui S; Talwar HS; Thind SK; Nath R; Rajendran L; Bapna BC
    Int J Clin Pharmacol Ther Toxicol; 1982 Sep; 20(9):434-7. PubMed ID: 7141762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Conservative therapy and prophylaxis of kidney calculi diseases].
    Solga U; Precht K
    Dtsch Gesundheitsw; 1968 Dec; 23(52):2463-7. PubMed ID: 5715946
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of magurlit for dissolving kidney stones].
    Baranyai E; Kiss E; Szebenyi R
    Urol Nefrol (Mosk); 1979; (5):12-4. PubMed ID: 43620
    [No Abstract]   [Full Text] [Related]  

  • 20. The importance of Magurlit in the prevention and dissolution of uric acid stones.
    Balogh F; Götz F; Köves S
    Ther Hung; 1980; 28(1):28-31. PubMed ID: 7281075
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.